BC Partners bought a BDC at 90% of NAV. Not every discount is worth chasing.
Target years worth of trading gains in mere days?
A note from our friends at Media Pub(ad) Let’s be real for a second. While most traders are still squinting…
Nvidia Is Down 30% From Its Peak. Tuesday Is the First Test.
Few earnings events in recent memory carry this many simultaneous inputs. Nvidia (NVDA) reports fiscal Q3 2027 results on Tuesday,…
SLL: Because Billions Could Pour into the Market that Day
November 16, 2026 Bonus Content: China’s October Miss: What It Means for Copper and Ore A note from our friends…
Washington Can Fix Its Books With Gold. Not Dollars.
A note from our friends at Newmont Capital_MP(ad) There is a monetary shift building that retirement savers will not see…
Democrats have won but the risks remain
A note from our friends at Weiss Ratings(ad) Dear Reader, Democrats have won both the House and the Senate. That…
Summit Therapeutics Paid $500 Million for Ivonescimab. The FDA Just Said No.
The rejection of Summit's lung cancer drug tests every Western thesis on Chinese oncology assets.
Alibaba Earnings Loom. The Stock Has Been Punished.
BABA reports Thu, Nov. 19 with EPS expected to jump year over year, but a 7% selloff shows export-control fear…
Tesla Is Selling You a Driverless Car. The Bill Is the Story.
A $29,990 Cybercab with a required $299 monthly plan reshapes Tesla’s model.
Nvidia’s Bond Market Is Asking a Question the Stock Price Is Ignoring
With $36 billion of AI cloud backstops now in doubt after Jensen Huang's exit, credit markets are pricing a financing…
